Use of peripheral-blood progenitor cells abrogates the myelotoxicity of repetitive outpatient high-dose carboplatin and cyclophosphamide chemotherapyTEPLER, I; CANNISTRA, S. A; SHEETS, E et al.Journal of clinical oncology. 1993, Vol 11, Num 8, pp 1583-1591, issn 0732-183XArticle

The collection and evaluation of peripheral blood progenitor cells sufficient for repetitive cycles of high-dose chemotherapy supportBENJAMIN, R. J; LINSLEY, L; GAYNES, L et al.Transfusion (Philadelphia, PA). 1995, Vol 35, Num 10, pp 837-844, issn 0041-1132Article

High-dose combined alkylating agent therapy with autologous stem cell support and chest radiotherapy for limited small-cell lung cancerELIAS, A. D; AYASH, L; SKARIN, A. T et al.Chest. 1993, Vol 103, Num 4, pp 433S-435S, issn 0012-3692, SUPConference Paper

Intensive combined modality therapy for limited-stage small-cell lung cancerELIAS, A. D; AYASH, L; MCCAULEY, M et al.Journal of the National Cancer Institute. 1993, Vol 85, Num 7, pp 559-566, issn 0027-8874Article

A phase II study of high-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapyANTMAN, K; AYASH, L; FREI, E. III et al.Journal of clinical oncology. 1992, Vol 10, Num 1, pp 102-110, issn 0732-183XArticle

Tacrolimus as monotherapy or combined with minidose methotrexate for graft-versus-host disease prophylaxis after allogeneic peripheral blood stem cell transplantation: long-term outcomesUBERTI, J. P; AYASH, L; BRAUN, T et al.Bone marrow transplantation (Basingstoke). 2004, Vol 34, Num 5, pp 425-431, issn 0268-3369, 7 p.Article

Prognostic factors for treatment outcome in autotransplantation of intermediate-grade and high-grade Non-Hodgkin's lymphoma with cyclophosphamide, carmustine, and etoposideWHEELER, C; STRAWDERMAN, M; WEINSTEIN, H et al.Journal of clinical oncology. 1993, Vol 11, Num 6, pp 1085-1091, issn 0732-183XArticle

Mobilization of peripheral blood progenitor cells by chemotherapy and granulocyte-macrophage colony-stimulating factor for hematologic support after high-dose intensification for breast cancerELIAS, A. D; AYASH, L; PELAEZ, J et al.Blood. 1992, Vol 79, Num 11, pp 3036-3044, issn 0006-4971Article

A phase I trial of continuous-infusion cyclophosphamide in refractory cancer patientsEDER, J. P; ELIAS, A. D; AYASH, L et al.Cancer chemotherapy and pharmacology. 1991, Vol 29, Num 1, pp 61-65, issn 0344-5704Article

GM-CSF potentiated peripheral blood progenitor cell (PBPC) collection with or without bone marrow as hematologic support of high-dose chemotherapy : two protocolsELIAS, A. D; MAZANET, R; SCHNIPPER, L et al.Breast cancer research and treatment. 1991, Vol 20, pp S25-S29, issn 0167-6806, SUPConference Paper

Long-term follow up of patients proceeding to transplant using plerixafor mobilized stem cells and incidence of secondary myelodysplastic syndrome/AMLDEOL, A; ABRAMS, J; MASOOD, A et al.Bone marrow transplantation (Basingstoke). 2013, Vol 48, Num 8, pp 1112-1116, issn 0268-3369, 5 p.Article

West Nile virus encephalitis causing fatal CNS toxicity after hematopoietic stem cell transplantationREDDY, P; DAVENPORT, R; RATANATHARATHORN, V et al.Bone marrow transplantation (Basingstoke). 2004, Vol 33, Num 1, pp 109-112, issn 0268-3369, 4 p.Article

Chronic graft-versus-host disease: clinical manifestation and therapyRATANATHARATHORN, V; AYASH, L; LAZARUS, H. M et al.Bone marrow transplantation (Basingstoke). 2001, Vol 28, Num 2, pp 121-129, issn 0268-3369Article

Pulmonary toxicity associated with high dose chemotherapy in the treatment of solid tumors with autologous marrow transplant : an analysis of four chemotherapy regimensSEIDEN, M. V; ELIAS, A; AYASH, L et al.Bone marrow transplantation (Basingstoke). 1992, Vol 10, Num 1, pp 57-63, issn 0268-3369Article

Combination of the minor groove-binder U73-975 or the intercalator mitoxantrone with antitumor alkylating agents in MCF-7 or MCF-7/CpAYASH, L; KORBUT, T; HERMAN, T. S et al.Cancer letters. 1991, Vol 61, Num 1, pp 7-14, issn 0304-3835Article

Large pericardial effusion as a complication in adults undergoing SCTNORKIN, M; RATANATHARATHORN, V; AYASH, L et al.Bone marrow transplantation (Basingstoke). 2011, Vol 46, Num 10, pp 1353-1356, issn 0268-3369, 4 p.Article

Nephrotic syndrome associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantationREDDY, P; JOHNSON, K; UBERTI, J. P et al.Bone marrow transplantation (Basingstoke). 2006, Vol 38, Num 5, pp 351-357, issn 0268-3369, 7 p.Article

A short course of induction chemotherapy followed by two cycles of high-dose chemotherapy with stem cell rescue for chemotherapy naive metastatic breast cancerELIAS, A. D; RICHARDSON, P; WHEELER, C et al.Bone marrow transplantation (Basingstoke). 2001, Vol 27, Num 3, pp 269-278, issn 0268-3369Article

Allogeneic stem cell transplantation reduces disease progression compared to autologous transplantation in patients with multiple myelomaREYNOLDS, C; RATANATHARATHORN, V; FERRARA, J et al.Bone marrow transplantation (Basingstoke). 2001, Vol 27, Num 8, pp 801-807, issn 0268-3369Article

Dose-intensive therapy for limited-stage small-cell lung cancer : Long-term outcomeELIAS, A; IBRAHIM, J; SKARIN, A. T et al.Journal of clinical oncology. 1999, Vol 17, Num 4, pp 1175-1184, issn 0732-183XArticle

Repetitive cycles of cyclophosphamide, thiotepa, and carboplatin intensification with peripheral-blood progenitor cells and filgrastim in advanced breast cancer patientsSHAPIRO, C. L; AYASH, L; HAYES, D et al.Journal of clinical oncology. 1997, Vol 15, Num 2, pp 674-683, issn 0732-183XArticle

Use of amifostine as a chemoprotectant during high-dose chemotherapy in autologous peripheral blood stem cell transplantationCRONIN, S; UBERTI, J. P; AYASH, L. J et al.Bone marrow transplantation (Basingstoke). 2000, Vol 26, Num 11, pp 1247-1249, issn 0268-3369Article

A preclinical model for sequential high-dose chemotherapyHOLDEN, S. A; TEICHER, B. A; AYASH, L. J et al.Cancer chemotherapy and pharmacology. 1995, Vol 36, Num 1, pp 61-64, issn 0344-5704Article

Antitumor efficacy and pharmacokinetic analysis of 4-hydroperoxycyclophosphamide in comparison with cyclophosphamide ± hepatic enzyme effectorsTEICHER, B. A; HOLDEN, S. A; GOFF, D. A et al.Cancer chemotherapy and pharmacology. 1996, Vol 38, Num 6, pp 553-560, issn 0344-5704Article

Kinetics of peripheral blood mononuclear cell mobilization with chemotherapy and/or granulocyte-colony-stimulating factor : implications for timing and yield of hematopoietic progenitor cell collectionsWEBB, I. J; EICKHOFF, C. E; ELIAS, A. D et al.Transfusion (Philadelphia, PA). 1996, Vol 36, Num 2, pp 160-167, issn 0041-1132Article